daunorubicin has been researched along with Aging in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alibhai, SM; Brandwein, JM; Breunis, H; Buckstein, R; Gupta, V; Li, M; Minden, MD; Mohamedali, H; Timilshina, N; Tomlinson, G | 1 |
| Burke, BE; Cusack, BJ; Gambliel, HA; Mushlin, PS; Olson, RD; Olson, SJ | 1 |
| Cusack, BJ; Gabliel, H; Olson, RD; Young, SP | 1 |
| Björkholm, M; Christenson, I; Engstedt, L; Gahrton, G; Hast, R; Holm, G; Killander, A; Lantz, B; Lockner, D; Lönnqvist, B; Mellstedt, H; Oberg, G; Palmblad, J; Paul, C; Peterson, C; Simonsson, B; Stalfelt, AM; Udén, AM; Wadman, B | 1 |
| Hählen, K; Huismans, DR; Kaspers, GJ; Loonen, AH; Pieters, R; van Wering, ER; Veerman, AJ | 1 |
| Cusack, BJ; Johnson, CJ; Mushlin, PS; Olson, RD; Vestal, RE | 1 |
| Cusack, BJ; Olson, RD; Vestal, RE; Young, SP | 1 |
| Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
| Cummings, J; Samuel, L; Shaw, P | 1 |
| Appelbaum, FR; Banker, DE; Cooper, JJ; Garrido, SM; Kopecky, K; Willman, CL | 1 |
| Amenomori, T; Atogami, S; Fukushima, T; Hayashibara, T; Honda, M; Ikeda, S; Jinnai, I; Kuriyama, K; Kusano, M; Matsuo, T; Miyazaki, Y; Momita, S; Nagai, K; Nonaka, H; Soda, H; Taguchi, J; Tomonaga, M; Toriya, K; Yoshida, S; Yoshida, Y | 1 |
| Auclerc, MF; Holland, JF; Jacquillat, C; Schaison, G; Weil, M | 1 |
| Futch, WS; Iwanik, M; Rosowsky, A; Schook, LB; Shaw, JM; Shaw, KV; Yanovich, S | 1 |
| Capizzi, RL; Cooper, MR; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Spurr, CL; Stuart, JJ; White, DR; Zekan, PJ | 1 |
| Kalant, N; Lui, S | 1 |
2 review(s) available for daunorubicin and Aging
| Article | Year |
|---|---|
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
2 trial(s) available for daunorubicin and Aging
| Article | Year |
|---|---|
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aging; Antibiotics, Antineoplastic; Bone Marrow Diseases; Clinical Trials as Topic; Daunorubicin; DNA; DNA Adducts; Female; Heart Diseases; Humans; Immunotherapy; Leukemia; Male; Middle Aged | 1981 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
12 other study(ies) available for daunorubicin and Aging
| Article | Year |
|---|---|
Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2012 |
Decreased sensitivity of neonatal rabbit sarcoplasmic reticulum to anthracycline cardiotoxicity.
Topics: Aging; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Caffeine; Daunorubicin; Doxorubicin; Female; Heart Atria; Heart Diseases; Male; Muscle Relaxation; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Rabbits; Sarcoplasmic Reticulum | 2002 |
Effect of aging on cardiac contractility in a rat model of chronic daunorubicin cardiotoxicity.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Calcium Channels; Cholesterol; Chronic Disease; Creatinine; Daunorubicin; Depression, Chemical; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Diseases; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Myocardium; Rats; Rats, Inbred F344; Sarcoplasmic Reticulum; Time Factors; Triglycerides; Ventricular Function, Left | 2002 |
Cellular drug resistance profiles that might explain the prognostic value of immunophenotype and age in childhood acute lymphoblastic leukemia.
Topics: Aging; Antineoplastic Agents; Child; Child, Preschool; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Immunophenotyping; Infant; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Predictive Value of Tests; Prognosis; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured; Vincristine | 1993 |
Aging increases the cardiotoxicity of daunorubicin and daunorubicinol in the rat.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Daunorubicin; Heart; In Vitro Techniques; Male; Myocardial Contraction; Rats; Rats, Inbred F344 | 1996 |
Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Area Under Curve; Cardiomyopathies; Daunorubicin; Half-Life; Injections, Intravenous; Male; Rats; Rats, Inbred F344 | 1997 |
Daunorubicin cardiotoxicity in childhood cancer.
Topics: Adult; Aging; Animals; Antibiotics, Antineoplastic; Child, Preschool; Daunorubicin; Heart; Humans; Mice; Neoplasms | 1998 |
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
Topics: Acute Disease; Adult; Aged; Aging; Antibiotics, Antineoplastic; Antigens, CD34; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Cells; Cell Cycle; Cytarabine; Daunorubicin; G2 Phase; Humans; Leukemia, Myeloid; Middle Aged; Mitosis; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; S Phase; Tumor Cells, Cultured | 2001 |
De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Karyotyping; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Prognosis; Treatment Outcome; Tretinoin | 2001 |
[Treatment of acute leukemia].
Topics: Acute Disease; Adolescent; Adult; Aging; Asparaginase; Child; Child, Preschool; Daunorubicin; Humans; Infant; Leukemia; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Methotrexate; Remission, Spontaneous; Time Factors | 1977 |
Delivery of lipophilic drugs using lipoproteins.
Topics: Aging; Animals; Antibodies, Monoclonal; Cell Adhesion Molecules; Chemistry, Pharmaceutical; Daunorubicin; Drug Carriers; Drug Resistance; Leukemia P388; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Models, Molecular; Receptors, LDL; Receptors, Scavenger | 1987 |
Carbohydrate of the glomerular basement membrane in normal and hephrotic rats.
Topics: Aging; Animals; Basement Membrane; Carbohydrates; Daunorubicin; Female; Fucose; Galactose; Galactosidases; Glucose; Glycoside Hydrolases; Hexosamines; Immune Sera; Kidney Glomerulus; Male; Mannose; Nephrosis; Neuraminic Acids; Rats | 1974 |